| |
|
|
| |
Pulmonary Inhalers & Inhaled Systemic Drug
Delivery
Devices, Drugs, Therapeutics, Market
Factors and Forecasts
|
Publication: May 2010
Product Code: PSD510R
|
Advances in drug formulation and inhalation device design
are creating new opportunities for inhaled drug delivery as
an alternative to oral and parenteral delivery methods. Much
of the interest in pulmonary delivery of systemic drug
therapies is focused on chronic diseases and refractory
conditions – aliments that require frequent drug
administration for a protracted period of time. The role of
device design and development in defining and driving
emerging opportunities in this sector cannot be overstated.
Several of the emerging drug products covered in this report
will have a significant impact in the therapeutic markets
they target, improving patient compliance and effectively
changing the way important illnesses and conditions are
treated. |
|
Highlights |
· Analyzes commercial
products and development-stage candidates within the
inhaled systemic drug delivery segment for fifteen major
therapeutic markets
· Examines inhaler design
factors and combination drug-device product technology
issues
· Provides detailed
assessments of targeted disease segments, growth rates
and market potential
· Forecasts the impact of
new and emerging inhaled systemic drug therapeutics on
healthcare markets and prescribing decisions
· Provides market data by
segment and forecasts demand to 2013
|
|
Summary of Contents |
Executive Summary
Inhaled Drug Delivery
Market Dynamics
Portrait of an Evolving
Market
Established Therapeutic Targets
Emerging Therapies
Demographics and Growth
Competing Technologies
Market Drivers
Factors
Limiting Growth
Inhaler Technology,
Commercial Devices & Formulation Factors
Inhaler Designs and Design Factors
Dry Powder
Inhalers
Metered Dose Inhalers
Nebulizers
Device Performance Factors
Drug Formulation
Factors
Bioavailability
Active Compound
Stability
Device Assessments
Commercial
Devices
Development-Stage Devices
Inhaled
Systemic Drugs – Therapeutic Segment Analysis,
Forecasts
and Outlook
Anaphylaxis
Cardiovascular Medicine
Hereditary Diseases
Immunology
Infectious Diseases
Metabolic
Growth Deficiencies
Osteoporosis
Neurology
Antipsychotics
Migraine
Parkinson’s
Oncology
Pain Management
Sexual Health
Market Factors
Device Packaging
Regulatory
Issues
Patient Compliance
The Role of
CMOs/CSOs
Healthcare Economics
Market
Sector Company Profiles
|
|
|
|
|
